Company / Tangible Book Value per Share
Celldex Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$7.92
FY2025
5-year range
$6.91 / $11.25
FY2021-FY2025
Trend
-29.6%
vs FY2024
Sector context
#58 of 159
Health Care
What the data says
At $7.92, Celldex Therapeutics, Inc.'s tangible book value per share ranks #58 of 159 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $1.21 in FY2017 to $28.74 in FY2018.
Based on SEC 10-K filings.
7.92 in FY2025 with a 5-year CAGR of +8.4%.
Improved from $7.68 to $7.92 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
-57.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 29.6% year-over-year.
- Ranks #58 out of 159 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.92 | -29.6% |
| FY2024 | $11.25 | +46.5% |
| FY2023 | $7.68 | +11.1% |
| FY2022 | $6.91 | -23.0% |
| FY2021 | $8.98 | +69.8% |
| FY2020 | $5.29 | -4.6% |
| FY2019 | $5.54 | -80.7% |
| FY2018 | $28.74 | +2282.5% |
| FY2017 | $1.21 | -16.7% |
| FY2016 | $1.45 | -49.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026